← Indices
Sectoral index
NIFTY PHARMA
20 constituents, as NSE currently publishes them.
Index level
26,438
30 Sept 2026 · -1.84%
Constituent market cap
₹20,45,000 Cr
summed over 20 of 20
P/E (cap-weighted)
41.2
median 42.0 · over 20 of 20
Median 1y return
—
over 0 of 20
Recent membership changes
dated when this ingest first saw the change, not when NSE made it- →Ajanta Pharma Limited10 Aug 2026
- →Alkem Laboratories Limited10 Aug 2026
- →Cipla10 Aug 2026
- →Divi's Laboratories10 Aug 2026
- →Gland Pharma Limited10 Aug 2026
- →Ipca Laboratories Limited10 Aug 2026
- →Laurus Labs Limited10 Aug 2026
- →Mankind Pharma Limited10 Aug 2026
- →Piramal Pharma Limited10 Aug 2026
- →Sun Pharmaceutical Industries10 Aug 2026
- →Torrent Pharmaceuticals Limited10 Aug 2026
- →Zydus Lifesciences Limited10 Aug 2026
Constituents
20, largest first| Company | Industry (NSE) | Market cap | P/E | ROE | Profit growth 1y | 1y return |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical IndustriesSUNPHARMA | Healthcare | ₹4,32,240 Cr | 35.7 | 14.7% | +5% | — |